ストックスクリーナーアプリを入手
54.72
1.05%
0.5636
前日終値:
$54.16
開ける：
$54.29
24時間の取引高:
1.23M
Relative Volume:
0.59
時価総額：
$10.52B
収益：
$2.95B
当期純損益:
$523.88M
株価収益率:
20.34
EPS:
2.69
ネットキャッシュフロー:
$620.18M
1週間 パフォーマンス:
+1.79%
1か月 パフォーマンス:
-6.08%
6か月 パフォーマンス:
-19.44%
1年 パフォーマンス:
-21.93%
1日の値動き範囲:
$54.26
$55.75
1週間の範囲:
$52.48
$55.75
52週間の値動き範囲:
$52.48
$73.51
Biomarin Pharmaceutical Inc Stock (BMRN) Company Profile
名前
Biomarin Pharmaceutical Inc
セクター
電話
(415) 506-6700
住所
105 DIGITAL DRIVE, NOVATO, CA
BMRN を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
BMRN
Biomarin Pharmaceutical Inc
|
54.77 | 10.40B | 2.95B | 523.88M | 620.18M | 2.69 |
|
VRTX
Vertex Pharmaceuticals Inc
|
403.64 | 100.41B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
605.96 | 59.59B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.86 | 59.77B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
773.12 | 45.14B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
343.13 | 37.42B | 3.81B | -644.79M | -669.77M | -6.24 |
Biomarin Pharmaceutical Inc Stock (BMRN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-09-08 | 開始されました | H.C. Wainwright | Neutral |
| 2025-09-03 | 開始されました | Raymond James | Outperform |
| 2025-07-03 | 再開されました | Morgan Stanley | Overweight |
| 2025-02-24 | アップグレード | Oppenheimer | Perform → Outperform |
| 2024-11-15 | 開始されました | Wolfe Research | Outperform |
| 2024-10-30 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2024-10-10 | 再開されました | Raymond James | Outperform |
| 2024-08-20 | アップグレード | Bernstein | Mkt Perform → Outperform |
| 2024-05-17 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2024-05-14 | 開始されました | Evercore ISI | Outperform |
| 2023-11-15 | 開始されました | Wells Fargo | Overweight |
| 2023-10-23 | アップグレード | Bernstein | Underperform → Mkt Perform |
| 2023-09-28 | 開始されました | Raymond James | Mkt Perform |
| 2023-09-18 | 開始されました | UBS | Buy |
| 2023-07-27 | 開始されました | Scotiabank | Sector Perform |
| 2023-07-05 | アップグレード | BMO Capital Markets | Market Perform → Outperform |
| 2023-06-14 | 再開されました | Credit Suisse | Outperform |
| 2023-03-21 | 開始されました | Bernstein | Underperform |
| 2023-02-22 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2023-02-21 | 開始されました | Citigroup | Neutral |
| 2023-01-30 | 開始されました | BMO Capital Markets | Market Perform |
| 2023-01-18 | 開始されました | Canaccord Genuity | Hold |
| 2022-10-31 | アップグレード | Oppenheimer | Perform → Outperform |
| 2022-07-13 | 開始されました | Cantor Fitzgerald | Overweight |
| 2022-06-13 | 再開されました | Wedbush | Neutral |
| 2022-04-25 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2021-11-22 | アップグレード | William Blair | Mkt Perform → Outperform |
| 2021-10-07 | 再開されました | Jefferies | Buy |
| 2021-09-09 | アップグレード | Stifel | Hold → Buy |
| 2021-06-04 | 再開されました | Robert W. Baird | Outperform |
| 2021-04-26 | 再開されました | Credit Suisse | Outperform |
| 2021-03-04 | 再開されました | Guggenheim | Buy |
| 2021-03-01 | アップグレード | Evercore ISI | In-line → Outperform |
| 2020-08-20 | ダウングレード | Citigroup | Buy → Neutral |
| 2020-08-20 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2020-08-19 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2020-08-19 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2020-08-19 | ダウングレード | Stifel | Buy → Hold |
| 2020-07-08 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2020-07-06 | 繰り返されました | Citigroup | Buy |
| 2020-01-28 | 開始されました | BMO Capital Markets | Market Perform |
| 2020-01-27 | 開始されました | BMO Capital Markets | Market Perform |
| 2020-01-24 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
| 2019-11-27 | アップグレード | Barclays | Equal Weight → Overweight |
| 2019-11-12 | 開始されました | SunTrust | Buy |
| 2019-10-17 | 再開されました | BofA/Merrill | Buy |
| 2019-05-23 | 再開されました | Citigroup | Buy |
| 2019-04-09 | 再開されました | Raymond James | Outperform |
| 2019-01-02 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2018-12-14 | 開始されました | Wolfe Research | Outperform |
| 2018-10-01 | 開始されました | Cantor Fitzgerald | Overweight |
| 2018-08-07 | 繰り返されました | Stifel | Buy |
| 2018-08-03 | 繰り返されました | Stifel | Buy |
すべてを表示
Biomarin Pharmaceutical Inc (BMRN) 最新ニュース
Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Growth Stock - Yahoo Finance
Take Care Before Diving Into The Deep End On BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) - 富途牛牛
Pompe Disease Market Analysis Report 2025-2035: Enzyme Replacement Therapies and Approvals of Myozyme and Nexviazyme Drive Steady Growth - GlobeNewswire Inc.
BioMarin: Valuation, Growth, And The Pipeline May Outweigh TransCon Competition And Regulatory Risks - Seeking Alpha
Tealwood Asset Management Inc. Increases Holdings in BioMarin Pharmaceutical Inc. $BMRN - MarketBeat
Raymond James Maintains a Buy Rating on BioMarin Pharmaceutical (BMRN), Sets a $85 PT - Yahoo Finance
Real time alert setup for BioMarin Pharmaceutical Inc. performanceCPI Data & Fast Moving Trade Plans - newser.com
Can BioMarin Pharmaceutical Inc. stock reach $100 price targetEarnings Trend Report & Precise Trade Entry Recommendations - newser.com
How BioMarin Pharmaceutical Inc. stock performs in stagflationRate Cut & Daily Profit Maximizing Trade Tips - newser.com
How institutional ownership impacts BioMarin Pharmaceutical Inc. stockJuly 2025 Update & Accurate Intraday Trading Signals - newser.com
BioMarin Pharmaceutical Inc. (BMRN) Stock Analysis: Exploring a Compelling 78% Upside Potential - DirectorsTalk Interviews
Is BioMarin Pharmaceutical Inc a good long term investmentRetail Investor Activity & Optimize Entry & Exit With Smart Signals - earlytimes.in
What analysts say about BioMarin Pharmaceutical Inc stockInsider Selling Patterns & Budget Friendly Trading Strategies - earlytimes.in
Is BioMarin Pharmaceutical Inc BM8 a good long term investmentPrice Volatility Patterns & Superior Wealth Growth - earlytimes.in
BioMarin Pharmaceutical Hits New 52-Week Low at $52.48 - Markets Mojo
Is BioMarin Pharmaceutical Inc. stock a safe buy before earningsPortfolio Growth Summary & Weekly Top Gainers Alerts - newser.com
Wealth Enhancement Advisory Services LLC Raises Stock Holdings in BioMarin Pharmaceutical Inc. $BMRN - MarketBeat
Biomarin Pharmaceutical stock hits 52-week low at $52.93 By Investing.com - Investing.com Nigeria
Perpetual Ltd Acquires New Stake in BioMarin Pharmaceutical Inc. $BMRN - MarketBeat
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Biomarin Pharmaceutical stock hits 52-week low at $52.93 - Investing.com India
BioMarin Pharmaceutical (NASDAQ:BMRN) Reaches New 12-Month LowTime to Sell? - MarketBeat
BioMarin Pharmaceutical Inc. $BMRN Shares Acquired by Covea Finance - MarketBeat
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Short Interest Update - MarketBeat
BioMarin Pharmaceutical Inc.(NasdaqGS: BMRN) dropped from FTSE All-World Index - MarketScreener
Assenagon Asset Management S.A. Purchases 230,362 Shares of BioMarin Pharmaceutical Inc. $BMRN - MarketBeat
Acadian Asset Management LLC Reduces Stake in BioMarin Pharmaceutical Inc. $BMRN - MarketBeat
Aug Movers: Why is BioMarin Pharmaceutical Inc. stock going upOil Prices & Community Trade Idea Sharing - خودرو بانک
BioMarin Pharmaceutical Inc. $BMRN Shares Sold by Intech Investment Management LLC - MarketBeat
Performance Recap: Should I invest in BioMarin Pharmaceutical Inc before earningsJuly 2025 Decliners & Expert Verified Movement Alerts - خودرو بانک
Wesbanco Bank Inc. Purchases 19,000 Shares of BioMarin Pharmaceutical Inc. $BMRN - MarketBeat
Why BioMarin Pharmaceutical (BMRN) is a Top Value Stock for the Long-Term - sharewise.com
Aug PreEarnings: What is the target price for BioMarin Pharmaceutical Inc stockBond Market & Fast Gain Stock Trading Tips - خودرو بانک
Aug Action: Is BioMarin Pharmaceutical Inc. stock forming a cup and handleWeekly Trend Summary & Stepwise Swing Trade Plans - khodrobank.com
Strs Ohio Takes Position in BioMarin Pharmaceutical Inc. $BMRN - MarketBeat
12 Best Beginner Stocks to Buy According to Analysts - Insider Monkey
Ideas Watch: How does BioMarin Pharmaceutical Inc score in quality rankingsEarnings Performance Report & Real-Time Buy Signal Notifications - خودرو بانک
Levels Update: Can BioMarin Pharmaceutical Inc. scale operations efficientlyQuarterly Trade Summary & Consistent Growth Equity Picks - khodrobank.com
BioMarin Pharmaceutical Inc.’s (BMRN) Phenylketonuria Candidate Drug Impresses in Phase 3 Trials - Insider Monkey
November 21st Options Now Available For BioMarin Pharmaceutical (BMRN) - Nasdaq
Leerink Partners Reiterates a Buy Rating on BioMarin Pharmaceutical (BMRN), Sets a PT of $105 - MSN
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Sells 5,118 Shares of BioMarin Pharmaceutical Inc. $BMRN - MarketBeat
BioMarin Pharmaceutical Inc. $BMRN Shares Bought by Goldman Sachs Group Inc. - MarketBeat
UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC Has $75.28 Million Stake in BioMarin Pharmaceutical Inc. $BMRN - MarketBeat
BMO Capital Reiterates a Buy on BioMarin Pharmaceutical (BMRN) - MSN
12 Affordable Biotech Stocks to Invest In Now - Insider Monkey
Biomarin Pharmaceutical Inc (BMRN) 財務データ
収益
当期純利益
現金流量
EPS
2.76%
大文字化:
|
ボリューム (24 時間):